These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
261 related articles for article (PubMed ID: 26925168)
21. QuBiLs-MAS method in early drug discovery and rational drug identification of antifungal agents. Medina Marrero R; Marrero-Ponce Y; Barigye SJ; Echeverría Díaz Y; Acevedo-Barrios R; Casañola-Martín GM; García Bernal M; Torrens F; Pérez-Giménez F SAR QSAR Environ Res; 2015; 26(11):943-58. PubMed ID: 26567876 [TBL] [Abstract][Full Text] [Related]
22. A Structure-Activity Relationship Study of Imidazole-5-Carboxylic Acid Derivatives as Angiotensin II Receptor Antagonists Combining 2D and 3D QSAR Methods. Sharma MC Interdiscip Sci; 2016 Mar; 8(1):1-10. PubMed ID: 26202941 [TBL] [Abstract][Full Text] [Related]
23. TOMOCOMD-CARDD descriptors-based virtual screening of tyrosinase inhibitors: evaluation of different classification model combinations using bond-based linear indices. Casañola-Martín GM; Marrero-Ponce Y; Khan MT; Ather A; Sultan S; Torrens F; Rotondo R Bioorg Med Chem; 2007 Feb; 15(3):1483-503. PubMed ID: 17110117 [TBL] [Abstract][Full Text] [Related]
24. Ensemble Models Based on QuBiLS-MAS Features and Shallow Learning for the Prediction of Drug-Induced Liver Toxicity: Improving Deep Learning and Traditional Approaches. Mora JR; Marrero-Ponce Y; García-Jacas CR; Suarez Causado A Chem Res Toxicol; 2020 Jul; 33(7):1855-1873. PubMed ID: 32406679 [TBL] [Abstract][Full Text] [Related]
25. Atom-based stochastic and non-stochastic 3D-chiral bilinear indices and their applications to central chirality codification. Castillo-Garit JA; Marrero-Ponce Y; Torrens F; Rotondo R J Mol Graph Model; 2007 Jul; 26(1):32-47. PubMed ID: 17110145 [TBL] [Abstract][Full Text] [Related]
26. Quantum mechanics-based properties for 3D-QSAR. El Kerdawy A; Güssregen S; Matter H; Hennemann M; Clark T J Chem Inf Model; 2013 Jun; 53(6):1486-502. PubMed ID: 23692495 [TBL] [Abstract][Full Text] [Related]
27. Improved 3D-QSAR prediction by multiple-conformational alignment: A case study on PTP1B inhibitors. Zhang X; Mao J; Li W; Koike K; Wang J Comput Biol Chem; 2019 Dec; 83():107134. PubMed ID: 31629257 [TBL] [Abstract][Full Text] [Related]
29. Linear indices of the "molecular pseudograph's atom adjacency matrix": definition, significance-interpretation, and application to QSAR analysis of flavone derivatives as HIV-1 integrase inhibitors. Marrero-Ponce Y J Chem Inf Comput Sci; 2004; 44(6):2010-26. PubMed ID: 15554670 [TBL] [Abstract][Full Text] [Related]
31. Application of GA-MLR for QSAR Modeling of the Arylthioindole Class of Tubulin Polymerization Inhibitors as Anticancer Agents. Ahmadi S; Habibpour E Anticancer Agents Med Chem; 2017; 17(4):552-565. PubMed ID: 27528182 [TBL] [Abstract][Full Text] [Related]
33. Bond-based 3D-chiral linear indices: theory and QSAR applications to central chirality codification. Castillo-Garit JA; Marrero-Ponce Y; Torrens F; García-Domenech R; Romero-Zaldivar V J Comput Chem; 2008 Nov; 29(15):2500-12. PubMed ID: 18470969 [TBL] [Abstract][Full Text] [Related]
34. 3D QSAR studies on protein tyrosine phosphatase 1B inhibitors: comparison of the quality and predictivity among 3D QSAR models obtained from different conformer-based alignments. Pandey G; Saxena AK J Chem Inf Model; 2006; 46(6):2579-90. PubMed ID: 17125198 [TBL] [Abstract][Full Text] [Related]
35. Predictive QSAR modeling of CCR5 antagonist piperidine derivatives using chemometric tools. Roy K; Mandal AS J Enzyme Inhib Med Chem; 2009 Feb; 24(1):205-23. PubMed ID: 18608745 [TBL] [Abstract][Full Text] [Related]
36. Analysis of B-Raf[Formula: see text] inhibitors using 2D and 3D-QSAR, molecular docking and pharmacophore studies. Aalizadeh R; Pourbasheer E; Ganjali MR Mol Divers; 2015 Nov; 19(4):915-30. PubMed ID: 26276566 [TBL] [Abstract][Full Text] [Related]
37. Comparison of Multiple Linear Regressions and Neural Networks based QSAR models for the design of new antitubercular compounds. Ventura C; Latino DA; Martins F Eur J Med Chem; 2013; 70():831-45. PubMed ID: 24246731 [TBL] [Abstract][Full Text] [Related]
38. QSAR modeling and in silico design of small-molecule inhibitors targeting the interaction between E3 ligase VHL and HIF-1α. Pan J; Zhang Y; Ran T; Xu A; Qiao X; Yin L; Zhou W; Zhu L; Zhao J; Lu T; Chen Y; Jiang Y Mol Divers; 2017 Aug; 21(3):719-739. PubMed ID: 28689235 [TBL] [Abstract][Full Text] [Related]
40. Beware of External Validation! - A Comparative Study of Several Validation Techniques used in QSAR Modelling. Majumdar S; Basak SC Curr Comput Aided Drug Des; 2018; 14(4):284-291. PubMed ID: 29701159 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]